Successful Treatment with Osimertinib Based on Therapeutic Drug Monitoring in a Hemodialysis Patient with Non-Small Cell Lung Cancer: A Case Report

Although osimertinib is a key drug in the treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation, the safety in hemodialysis patients has not been established. A 76-year-old man was diagnosed with NSCLC with EGFR deletion mutation in exon 19. After trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Keisuke, Aoki, Masaya, Miyata, Ryo, Umehara, Tadashi, Harada-Takeda, Aya, Kamimura, Go, Nagata, Toshiyuki, Okizono, Ryuya, Terazono, Hideyuki, Takeda, Yasuo, Suetsugu, Takayuki, Ueda, Kazuhiro, Sato, Masami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626281/
https://www.ncbi.nlm.nih.gov/pubmed/37936662
http://dx.doi.org/10.1159/000531840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626281/
https://www.ncbi.nlm.nih.gov/pubmed/37936662
http://dx.doi.org/10.1159/000531840

Ejemplares similares